1. Home
  2. NEO vs BRAI Comparison

NEO vs BRAI Comparison

Compare NEO & BRAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$15.11

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Braiin Limited Common Stock

BRAI

Braiin Limited Common Stock

N/A

Current Price

$6.05

Market Cap

1.3B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
NEO
BRAI
Founded
2001
N/A
Country
United States
Australia
Employees
N/A
N/A
Industry
Precision Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
NEO
BRAI
Price
$15.11
$6.05
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$13.38
N/A
AVG Volume (30 Days)
3.4M
170.0K
Earning Date
04-28-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.63
N/A
Revenue Next Year
$9.73
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.72
$5.25
52 Week High
$15.56
$32.32

Technical Indicators

Market Signals
Indicator
NEO
BRAI
Relative Strength Index (RSI) 83.10 39.61
Support Level $11.49 N/A
Resistance Level N/A $11.57
Average True Range (ATR) 0.70 1.16
MACD 0.33 0.01
Stochastic Oscillator 92.82 12.34

Price Performance

Historical Comparison
NEO
BRAI

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About BRAI Braiin Limited Common Stock

Braiin Ltd is an Australian technology company leveraging proprietary intellectual property and patented artificial intelligence/machine learning (AI/ML) technologies to deliver actionable insights across the verticals: Agriculture, Property Technology, and Customer Experience as a Service (CXaaS). The company's platforms are designed to address inefficiencies and drive data-backed decision-making across traditionally analog sectors. It prominently focuses on the agriculture technology sector, where it has successfully deployed its AI-powered solutions across multiple implementations. It provides end-to-end solutions to improve farming productivity using IoTs, Wireless Connectivity, Robotics, Software and AI/ML.

Share on Social Networks: